Hongbing Huang
-
- Renal Transplantation Outcomes and Treatments 2
-
- CAR-T cell therapy research 3
- Drug Transport and Resistance Mechanisms 2
- Pancreatic and Hepatic Oncology Research 2
-
- Pharmaceutical Practices and Patient Outcomes 3
-
- Chronic Lymphocytic Leukemia Research 5
-
- Lymphoma Diagnosis and Treatment 4
-
- Anesthesia and Neurotoxicity Research 2
- Journals
- SHILAP Revista de lepidopterología (1 paper)Cancer Research (1 paper)Annals of Oncology (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Hongbing Huang
22 papers receiving 379 citations
Peers
Comparison fields: 5 of 79
- Transplantation 17
- Neurology 42
- Cancer Research 69
- Oncology 124
- Geriatrics and Gerontology 17
Countries citing papers authored by Hongbing Huang
This map shows the geographic impact of Hongbing Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbing Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbing Huang more than expected).
Fields of papers citing papers by Hongbing Huang
This network shows the impact of papers produced by Hongbing Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbing Huang. The network helps show where Hongbing Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongbing Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 42 | |
| 5 | Working mode of oncology surgical pharmacy in China. | 2022 | 0 |
| 6 | 2021 | 4 | |
| 7 | 2021 | 2 | |
| 8 | 2020 | 5 | |
| 9 | 2020 | 19 | |
| 10 | 2020 | 21 | |
| 11 | 2019 | 0 | |
| 12 | 2017 | 81 | |
| 13 | 2017 | 2 | |
| 14 | 2016 | 45 | |
| 15 | 2016 | 15 | |
| 16 | 2013 | 25 | |
| 17 | 2012 | 86 | |
| 18 | 2012 | 10 | |
| 19 | 2012 | 4 | |
| 20 | [Exploring the potential molecular target proteins of yinchenhao decoction using computer systemic biology]. | 2011 | 2 |
About Hongbing Huang
Hongbing Huang is a scholar working on Geriatrics and Gerontology, Transplantation and Developmental Neuroscience, having authored 24 papers that have together received 383 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers), CAR-T cell therapy research (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Renal Transplantation Outcomes and Treatments (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Anesthesia and Neurotoxicity Research (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Transplantation (17 citations), Neurology (42 citations) and Cancer Research (69 citations). Hongbing Huang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Minghua Li, Tao Luo, Min Liu, Jianjun Liu, Xu Zhang, Xiaokun Wang, Kenneth K.W. To, Liwu Fu, Fang Wang and Zhou Wang. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.